期刊文献+

韧带样型纤维瘤病的临床病理学及遗传学研究 被引量:40

Clinicopathologic and genetic studies of desmoid-type fibromatosis
原文传递
导出
摘要 目的研究韧带样型纤维瘤病的临床病理学和遗传学特点,探讨用荧光原位杂交的方法在石蜡包埋组织中检测8号染色体三体的可行性。方法分析96例韧带样型纤维瘤病的临床资料,对69例进行组织学形态和免疫学表型分析(免疫组织化学EnVision两步法,抗体包括波形蛋白、结蛋白、α平滑肌肌动蛋白、βcatenin、CD34、CD117、S100)、对2例行电镜观察,采用荧光原位杂交检测20例石蜡包埋组织中的8号染色体三体。结果96例病例中男20例,女76例,年龄范围8~86岁,平均35.3岁。腹部以外部位的病变44例,腹壁和盆腔的病变28例,腹腔内病变23例,其中2例与Gardner综合征伴发。病变直径在0.6~24.0cm之间,平均8.4cm,结节或者条索状肿块,质地韧,切面粗糙。显微镜下形态较一致的梭形细胞分布于大量增生的胶原纤维间质内,梭形的纤维母细胞和肌纤维母细胞常排列成束状,胞质界限不清,细胞异形性不明显。透射电镜下,纤维母细胞有丰富的粗面内质网和发达的高尔基复合体,肌纤维母细胞还可以看到应力纤维、纤维连接复合体、中间连接和缝隙连接。所有病例均表达波形蛋白,部分病例还表达结蛋白和α平滑肌肌动蛋白。βcatenin胞质和核的异位表达阳性率为47.8%(33/69)。8号染色体三体阳性率为30.0%(6/20),原发病例中8号染色体三体阳性率为1/12,显著低于复发病例的5/8。结论韧带样型纤维瘤病是主要发生于年轻女性的中间型肿瘤。它主要由纤维母细胞和肌纤维母细胞构成,而肌纤维母细胞有应力纤维、纤维连接复合体等特征性结构。可用荧光原位杂交方法在石蜡组织中检测8号染色体三体,其可能为韧带样型纤维瘤病的复发预测因子,并界定某种高复发风险亚型。 Objective To study the clinicopathological and genetic features of desmoid-type fibromatosis, and to investigate the feasibility of detecting trisomy 8 in formalin fixed, paraffin embedded (FFPE) tissue by fluorescence in-situ hybridization (FISH). Methods A total of 96 cases were included in this study. All patients had clinical information. Histopathologic and immunohistochemical evaluations were available in 69 cases, and ultrastructural evaluation was done in 2 cases of desmoid-type fibromatosis. FFPE tissue sections were available in 20 tumors for the trisomy 8 detection by FISH. Results There were 20 male and 76 female patients with ages ranging from 8 to 86 years ( mean 35.3 years). Clinically, there were 44 extra-abdominal tumors, 28 abdominal wall tumors and 23 intra-abdominal lesions mostly involving the mesentery. Most cases presented with nodular or funicular masses with white firm cut surfaces, measuring 0. 6 to 24.0 cm (mean 8.4 cm) in size. Histologically, desmoid-type fibromatoses showed longitudinal fascicles of spindle fibroblasts and myofibroblasts in a predominantly collagenous background. The tumor cells stained positive for vimentin, α-smooth muscle actin, desmin, and beta-catenin (47.8% , 33/69). Ultrastructurally, most tumor cells had features of fibroblasts, including rich endoplasmic reticulum and Golgi apparatus. Some tumor cells were myofibroblast-like cells exhibiting intercellular junctions, fibronexous junctions and stress fibers. Trisomy 8 was detected in 6 of 20 cases of desmoid-type fibromatosis including 5 of the 8 recurrent tumors but only one of the 12 primary tumors. The latter tumor also recurred three years later. Conclusions Desmoid-type fibromatosis is an intermediate (locally aggressive) tumor that occurs predominantly in young females. The lesion consists of fibroblasts and myofibroblasts with the latter showing characteristic features including stress fibers and fibronexous junctions. Trisomy 8 can be detected in FFPE tissue by FISH, and its presence serves as a useful predictor of tumor recurrence and may define a subtype of desmoid-type fibromatosis with high recurrence rate.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2006年第3期145-150,共6页 Chinese Journal of Pathology
关键词 纤维瘤病 原位杂交 荧光 染色体 8对 Fibromatosis In situ hybridization,fluorescence Chromosomes,human,pair 8
  • 相关文献

参考文献15

  • 1Miettinen M.Desmoid-type fibromatosis(aggressive fibromatosis).In:Miettinen M,eds.Diagnostic soft tissue pathology.New York:Churchill Livingstone,2003.162-164.
  • 2Goldblum J,Fletcher JA.Desmoid-type fibromatosis.In:Fletcher CDM,Unni KK,Mertens F,eds.World Health Organization Classification of Tumors:Pathology and Genetics of Tumors of Soft Tissue and Bone.Lyon:IARC Press,2002.83-84.
  • 3Maruyama K,Ochiai A,Akimoto S,et al.Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer.Oncology,2000,59:302-309.
  • 4Hayry P,Reitamo JJ,Totterman S,et al.The desmoid tumor.Ⅱ.Analysis of factors possibly contributing to the etiology and growth behavior.Am J Clin Pathol,1982,77:674-680.
  • 5Dequanter D,Gebhart M.Desmoid tumors.J Chir,2002,139:236-239.
  • 6Eyden B.Electron microscopy in the study of myofibroblastic lesions.Semin Diagn Pathol,2003,20:13-24.
  • 7Montgomery E,Torbenson MS,Kaushal M,et al.β-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis.Am J Surg Pathol,2002,26:1296-1301.
  • 8Fletcher JA,Naeem R,Xiao S,et al.Chromosome aberration in desmoid tumors.Trisomy 8 may be a predicator of recurrence.Cancer Genet Cytogenet,1995,79:139-143.
  • 9Dal Cin P,Sciot R,Aly MS,et al.Some desmoid tumors are characterized by trisomy 8.Genes Chromosomes Cancer,1994,10:131-135.
  • 10Larramendy ML,Virolainen M,Tukiainen E,et al.Chromosome band 1q21 is recurrently gained in desmoid tumors.Genes Chromosomes Cancer,1998,23:183-186.

二级参考文献35

  • 1Li C, Bapat B, Alman BA. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis. Am J Pathol, 1998,153:709-714.
  • 2Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis(desmoid tumor). Oncogene,1999,18:6615-6620.
  • 3Saito T, Oda Y, Kawaguchi K, et al. Possible association between higher 13-catenin mRNA expression and mutated β-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan plolymerase chain reaction. Lab Invest,2002,82:97-103.
  • 4Denys H,Jadidizadeh A, Amini Nik S,et al. Identification of IGFBP-6 as a significantly downregulatied gene by beta-catenin in desmoid tumors. Oncogene ,2004,23:654-664.
  • 5Olmeda D, Castel S, Vilaro S, et al. β-catenin regulation during the cycle: implications in G2/M and apoptosis. Mol Bio Cell,2003,14:2844-2860.
  • 6Forus A, Weghuis DO, Smeets D, et al. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer,1995,14:8-14.
  • 7Knuutila S, Bjorkqvist AM, Autio K, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol, 1998,152 : 1107-1123.
  • 8Tolg C, Poon R, Fodde R, et al. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis(desmoid tumor). Oncogene,2003 ,22 :6873-6882.
  • 9Miettinen M. Desmoid-type fibromatosis (aggressive fibromatosis ).In: Miettinen M, ed. Dignostic soft tissue pathology. New York:Churchill Livingstone, 2003. 162-164.
  • 10Goldblum J, Fletcher JA. Desmoid-type fibromatosis. In : Fletcher CD, Unni KK, Mertens F, eds. World Health Organization classification of tumors : pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press,2002.83-84.

共引文献51

同被引文献287

引证文献40

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部